GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krka DD (WAR:KRK) » Definitions » ROE % Adjusted to Book Value

Krka DD (WAR:KRK) ROE % Adjusted to Book Value : 5.85% (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Krka DD ROE % Adjusted to Book Value?

Krka DD's ROE % for the quarter that ended in Sep. 2024 was 10.53%. Krka DD's PB Ratio for the quarter that ended in Sep. 2024 was 1.80. Krka DD's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 was 5.85%.


Krka DD ROE % Adjusted to Book Value Historical Data

The historical data trend for Krka DD's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Krka DD ROE % Adjusted to Book Value Chart

Krka DD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.75 11.43 8.34 11.82 9.54

Krka DD Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.02 9.58 10.34 11.92 5.85

Competitive Comparison of Krka DD's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Krka DD's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Krka DD's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Krka DD's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Krka DD's ROE % Adjusted to Book Value falls into.



Krka DD ROE % Adjusted to Book Value Calculation

Krka DD's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=14.88% / 1.56
=9.54%

Krka DD's ROE % Adjusted to Book Value for the quarter that ended in Sep. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=10.53% / 1.80
=5.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Krka DD ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Krka DD's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Krka DD Business Description

Industry
Traded in Other Exchanges
Address
Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, East Europe region, and Others. The company derives a majority of its revenue from the European Union.

Krka DD Headlines

No Headlines